R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Status
- RECRUITING
- Phase
- PHASE2
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial
- Status
- RECRUITING
- Phase
- PHASE3
Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
- Status
- RECRUITING
- Phase
- PHASE3
Chidamide in Patients With Recurrent and Refractory Diffuse Large b
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Prognostic Model of Rituximab in the Treatment of MN
- Status
- UNKNOWN
- Phase
- N/A
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
- Status
- RECRUITING
- Phase
- N/A
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2